$102.80
-2.21-2.10%
At Close: -
$102.80
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Ligand Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ligand Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $1.40 | $0.98 | 42.9 % |
Mar 2024 | 2024-05-07 | $3.84 | $0.78 | 392.3 % |
Dec 2023 | 2024-02-27 | $1.38 | $0.66 | 109.1 % |
Sep 2023 | 2023-11-08 | $1.02 | $0.61 | 67.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $41.53M | $31.90M | 30.2 % |
Mar 2024 | 2024-05-07 | $30.98M | $27.92M | 10.9 % |
Dec 2023 | 2024-02-27 | $28.10M | $25.72M | 9.26 % |
Sep 2023 | 2023-11-08 | $32.87M | $27.19M | 20.9 % |
Ligand Pharmaceuticals (LGND) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $1.40, which beat the estimate of $0.98.
The Actual Revenue was $41.5M, which beat the estimate of $31.9M.
Browse earnings estimates, EPS, and revenue on all stocks.